InfraScan, Inc. of Philadelphia, PA at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

InfraScan, Inc.

3508 Market Street, Suite 127, 19104 Philadelphia, PA
Telephone +1 215 3876784
Fax +1 215 3862327

This company is co-exhibitor of
State of Pennsylvania Office of International Business Development

Hall map

MEDICA 2018 hall map (Hall 16): stand G05

Fairground map

MEDICA 2018 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.06  Neurological diagnosis, apparatus and instruments

Neurological diagnosis, apparatus and instruments

Our products

Product category: Neurological diagnosis, apparatus and instruments

Infrascanner® 2000

Near Infrared (NIR) Technology in Infrascanner
The basic method for intracranial hematomas detection with NIR spectroscopy is based on the differential light absorption associated with the injured versus the non-injured parts of brain. Read Our Whitepaper on NIR The Infrascanner compares the left and right sides of the brain in four different areas. The NIRS sensor is placed successively in the left and right frontal, temporal, parietal, and occipital areas of the head and the absorbance of light at selected wavelengths is recorded.

  • Patient measurement is completed within 2-3 minutes
  • Detects hematomas greater than 3.5 cc in volume
  • Detects hematomas up to 2.5 cm deep from the surface of the brain (or 3.5 cm from the skin surface)
  • Accuracy: In patients with Epidural, Subdural and Intracerebral hematomas: Sensitivity = 88% / Specificity = 90.7%*
* C. Robertson, E. Zager, R. Narayan, N. Handly, A. Sharma, D. Hanley, H. Garza, E. Maloney-Wilensky, J. Plaum, and C. Koenig, “Clinical Evaluation of a Portable Near-Infrared Device for Detection of Traumatic Intracranial Hematomas,” Journal of Neurotrauma, vol. 27, pp. 1597-1604, 2010.

More Less

About us

Company details

Makers of Infrascanner
InfraScan, Inc. is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma.

Intracranial hematomas are an important and, if diagnosed early, treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries, and 40% of them have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. The Office of Naval Research funded the company in May, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multi-center clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a denovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.

More Less